Jiangxi Rimag Group Co., Ltd. Class H stock analysis
Want to see HK:2522 full AI Analyst Report?
Jiangxi Rimag Group Co., Ltd. Class H (2522) Stock Price & Analysis
2522 Stock Chart & Stats
- Day’s Range
- HKD 4.16 - HKD 4.43
- 52-Week Range
- HKD 3.74 - HKD 18.51
- Previous Close
- HKD 4.26
- Volume
- N/A
- Average Volume (3M)
- 205.98K
- Market Cap
- HKD 1.92B
- Enterprise Value
- HKD 1.98B
- Total Cash (Recent Filing)
- HKD 585.83M
- Total Debt (Recent Filing)
- HKD 703.76M
- Price to Earnings (P/E)
- ―
- Beta
- 0.81
- Next Earnings
- Mar 26, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Recovery
The return to revenue growth indicates that the company regained some operating momentum after the prior-year contraction. If maintained, improving sales provide a stronger base for absorbing fixed costs, supporting investment, and rebuilding earnings capacity over the next several quarters.
Balance Sheet Strength
A meaningful equity base relative to debt gives the company a comparatively solid financial foundation. This structure can provide flexibility to manage obligations and fund operations, while reducing the immediate pressure that heavier leverage would place on future capital allocation.
Operating Cash Flow Rebound
The sharp improvement in operating cash flow and return to positive free cash flow show that cash conversion recovered materially in 2025. This strengthens the company’s ability to support ongoing operations and investment internally, although consistency remains important.
Bears Say
Thin And Volatile Profitability
The small 2025 profit remains well below the 2023 level and follows a sizable loss, demonstrating that earnings have not yet stabilized. Such volatility limits confidence in recurring profitability and leaves shareholder returns sensitive to changes in operating performance.
Rising Debt
Although debt remains below equity, its increase since 2023 raises the company’s financial commitments while profitability is still inconsistent. Greater borrowing can reduce flexibility if earnings remain weak and may constrain the resources available for growth or shareholder returns.
Uneven Free Cash Flow
The large swing from deeply negative free cash flow to a modest positive result shows that cash available after investment can vary substantially. This reduces the reliability of internally generated funds for expansion, debt reduction, or distributions over the medium term.
Jiangxi Rimag Group Co., Ltd. Class H News
2522 FAQ
What was Jiangxi Rimag Group Co., Ltd. Class H’s price range in the past 12 months?
What is Jiangxi Rimag Group Co., Ltd. Class H’s market cap?
When is Jiangxi Rimag Group Co., Ltd. Class H’s upcoming earnings report date?
How were Jiangxi Rimag Group Co., Ltd. Class H’s earnings last quarter?
Is Jiangxi Rimag Group Co., Ltd. Class H overvalued?
Does Jiangxi Rimag Group Co., Ltd. Class H pay dividends?
What is Jiangxi Rimag Group Co., Ltd. Class H’s EPS estimate?
How many shares outstanding does Jiangxi Rimag Group Co., Ltd. Class H have?
What happened to Jiangxi Rimag Group Co., Ltd. Class H’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Jiangxi Rimag Group Co., Ltd. Class H?
What is the TipRanks Smart Score and how is it calculated?
Jiangxi Rimag Group Co., Ltd. Class H Stock Smart Score
Company Description
Jiangxi Rimag Group Co., Ltd. Class H
Operating across China, Jiangxi Rimag Group Co., Ltd. specializes in providing medical imaging services. The company delivers a comprehensive suite of diagnostic imaging procedures, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography, serving both patients and other healthcare sector clients. It also offers sophisticated imaging solution services. Additionally, Rimag Cloud provides various digital offerings such as cloud-based storage and film modules, a cloud radiology information system (RIS), a cloud Picture Archive and Communication System (PACS), alongside modules for AI integration and operational management within imaging platforms. The firm also oversees and manages a medical imaging platform that hosts a diverse range of imaging-related services. Supporting its activities is a dedicated research and development center, and it further engages in the distribution of medical equipment and related consumables. Established in 2014, the company maintains its primary office in Beijing, China.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Zhaoyang Chen
- Employees
- 1,390
- Website
- www.rimag.com.cn
- Address
- CN
Jiangxi Rimag Group Co., Ltd. Class H (2522) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 6 | 11 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 4 | 0 | 8 |










